Search Results
You are looking at 1 - 1 of 1 items for
- Author: S. R. Page x
- Refine by access: All content x
Search for other papers by S. R. Page in
Google Scholar
PubMed
Search for other papers by A. H. Taylor in
Google Scholar
PubMed
Search for other papers by W. Driscoll in
Google Scholar
PubMed
Search for other papers by M. Baines in
Google Scholar
PubMed
Search for other papers by R. Thorpe in
Google Scholar
PubMed
Search for other papers by A. P. Johnstone in
Google Scholar
PubMed
Search for other papers by S. S. Nussey in
Google Scholar
PubMed
Search for other papers by G. St J. Whitley in
Google Scholar
PubMed
ABSTRACT
The mechanism by which monoclonal antibodies enhance the biological activity of a number of hormones is poorly understood. One such antibody (GC73), which binds to human but not bovine TSH, enhances the bioactivity of human TSH in vivo. We have investigated whether GC73 enhancement of TSH bioactivity involves potentiation of hormone-receptor activation assessed by the cyclic AMP (cAMP) responses of both primary human thyrocyte cultures and a TSH-responsive human thyrocyte cell line (SGHTL-45). GC73 had no effect on basal cAMP production. In contrast to its enhancement of the bioactivity of human TSH in vivo, it markedly inhibited the cAMP response to 1 and 10 mU human TSH/ml in primary thyrocytes. This effect was dose-dependent with neutralization of the bioactivity of TSH occurring at 2 mg GC73/ml. GC73 had no effect on the bioactivity of bovine TSH. In contrast, a second anti-TSH monoclonal antibody (TC12), which binds to both human and bovine TSH, inhibited the bioactivity of both species of TSH. Similar results were obtained using SGHTL-45 cells, although the peak concentrations of cAMP were lower. We conclude that binding of GC73 to human TSH resulted in inhibition rather than enhancement of the in-vitro biological activity of human TSH. We suggest that GC73 enhancement of human TSH bioactivity seen in vivo does not result from a mechanism involving potentiation of receptor activation by human TSH.
Journal of Endocrinology (1990) 126, 333–340
